analysts forecast the global clinical mass spectrometry market to grow
at a CAGR of close to 8% during the forecast period, according to
their latest market research report. The growth momentum of the market
is expected to accelerate in the year-over-year growth.
The increasing demand for clinical mass spectrometry in personalized
medicine is one of the major trends being witnessed in the global
clinical mass spectrometry market 2019-2023. Personalized
medicine refers to providing medical treatment according to the
individual characteristics of patients and offers the potential to
detect diseases at an earlier stage when treatment can be effective.
Personalized medicine increases the quality of clinical practice and
targeted care pathways and ultimately reduces the overall healthcare
costs. There is a growing popularity of using clinical mass
spectrometers in the development of personalized medicine for the early
detection of diseases and the selection of accurate treatment methods
that can reduce mortality rates. Such developments will drive the growth
of the market.
This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing
According to Technavio analysts, one of the key factors contributing to
the growth of the global clinical mass spectrometry market is the rise
in aging population:
Global clinical mass spectrometry market: Rise
in aging population
The increase in median age due to the increase in life expectancy has
resulted in an increase in the aging population globally. As the elderly
generally have low immunity and metabolism, they need to undergo
diagnostic tests such as microbial testing on a regular basis. This
results in an increased demand for clinical mass spectrometry that
reveals details about the casual microorganisms, based on which, the
physician decides the best course of treatment.
According to a senior analyst at Technavio, “In 2017, the World Bank
highlighted that the number of people aged 65 years and above accounted
for 8.69% of the global population. Thus, the increase in the aging
population globally would drive the demand for microbial testing.
Microbial identification with the help of clinical mass spectrometry
provides several advantages such as it is easy to use and reduces the
requirement for technical manpower. It is a reliable, rapid, and
cost-effective technique for the identification of microorganisms.”
Global clinical mass spectrometry market:
The global clinical mass spectrometry market research report provides
market segmentation by end user (healthcare and clinical research
laboratory) and by region (the Americas, EMEA, and APAC). It provides an
in-depth analysis of the prominent factors influencing the market,
including drivers, opportunities, trends, and industry-specific
The Americas held the largest share of the market in 2018, accounting
for more than 41% share. It was followed by EMEA and APAC respectively.
The Americas owns the largest share of the market owing to the increase
in the number of research studies for discovering new therapies for
diseases such as cancer.
Looking for more information on this market? Request
a free sample report
Technavio’s sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.
Some of the key topics covered in the report include:
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market size and forecast
Five Forces Analysis
- Regional comparison
- Key leading countries
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team
at [email protected].
Media & Marketing Executive
+1 844 364 1100
UK: +44 203 893 3200